Skip to main content
SpringerLink
Log in

LC Method for the Determination of NPC1161, Primaquine and their Metabolites in Various Biological Systems

  • Short Communication
  • Published:
Chromatographia Aims and scope Submit manuscript

Abstract

NPC1161 is an 8-aminoquinoline anti-malarial analog, which has a favorable toxicity profile relative to primaquine and other 8-aminoquinolines. High-performance liquid chromatographic method was developed for the determination of NPC1161, primaquine and their metabolites in biological samples in order to facilitate metabolic and pharmacokinetic studies. The method includes extraction of the unchanged drugs and their metabolites from the biological samples. Separation was achieved by reversed-phase chromatography on a C18 column with water–acetonitrile both containing 0.025% trifluoroacetic acid as the mobile phase. Recoveries of NPC1161 and its metabolites were greater than 60% in various biological samples tested. No interference with the components of the biological material was observed. The detector response was linear with concentrations of NPC1161 and its metabolites (desalkyl NPC1161 and carboxy NPC1161) in the ranges from 0.5 to 80.0, 0.4–60.0 and 0.4–70.0 μg mL−1, respectively. A mass spectrometry coupled with electrospray ionization (ESI) interface method is described for the identification of NPC1161 and its metabolites in biological samples. This method involved the use of the [M + H]+ions of NPC1161, C3 analog (internal std. for the assay), desalkyl NPC1161 and carboxy NPC1161 at m/z 434, 406, 349 and 449 in the positive ion mode with extractive ion monitoring (EIM). This method will have an important application in pharmacokinetic studies of NPC1161 and in understanding the mechanism of metabolism of this novel 8-aminoquinoline analog in more detail.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

References

  1. Hartl DL (2003) Nat Rev Microbiol 2:15–22

    Article  Google Scholar 

  2. Baird JK, Hoffman SL (2004) Clin Infect Dis 39:1336–1345

    Article  CAS  Google Scholar 

  3. Taylor WR, White NJ (2004) Drug Safety 27:25–61

    Article  CAS  Google Scholar 

  4. Wiesner J, Ortmann R, Jomaa H, Schlitzer M (2003) Chem Int Ed Engl 42:5274–5293

    Article  CAS  Google Scholar 

  5. Peters W, Stewart LB, Robinson BL (2003) Ann Trop Med Parasitol 97:221–236

    Article  CAS  Google Scholar 

  6. Chen LH, Keystone JS (2005) Infect Dis Clin North Am 19:185–210

    Article  Google Scholar 

  7. McChesney J, Nanayakkara NPD, Bartlett M, Agar AL (2000) 8-Aminoquinolines, US patent No US 6376511 B2

  8. Nan A, Nanayakkara NP, Walker LA, Yardley V, Croft SL, Ghandehari H (2001) J Control Release 77:233–243

    Article  CAS  Google Scholar 

  9. Brueckner RP, Colin O, Baird JK, Milhous WK (2001) 8-Aminoquinolines. In: Rosenthal PJ (eds) Antimalarial chemotherapy: mechanism of action, resistance and new directions in drug discovery. Humana press Totowa, New Jersey, USA, pp. 123–151

    Google Scholar 

  10. ElSohly MA, Gul W, Feng S, Nanayakkara NPD, Clark AM, Khan SI, Cogswell FB, Walker LA (2006) Chromatographia (in press)

  11. Baker JK, McChesney JD, Hufford CD, Clark AM (1982) J Chromatogr A 230:69–77

    CAS  Google Scholar 

  12. LaMontagne MP, Blumbergs P, Strube RE (1982) Am Chem Soc 25:1094–1097

    CAS  Google Scholar 

Download references

Acknowledgment

Supported in part by Medicines for Malaria Venture (Geneva) and the National Centre for Natural Products Research (University of Mississippi).

Author information

Authors and Affiliations

  1. National Center for Natural Products Research, Research Institute of Pharmaceutical Sciences, Mississippi, MS, USA

    B. Avula, L. M. Tripathi, S. I. Khan, B. L. Tekwani, D. Nanayakkara, W. Gul, M. A. ElSohly & I. A. Khan

  2. Department of Pharmacognosy, School of Pharmacy, The University of Mississippi, Mississippi, MS, 38677, USA

    I. A. Khan

  3. ElSohly Laboratories, Incorporated, 5 Industrial Park Drive, Oxford, Mississippi, 38655, USA

    W. Gul & M. A. ElSohly

Authors
  1. B. Avula
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L. M. Tripathi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. I. Khan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. B. L. Tekwani
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. D. Nanayakkara
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. W. Gul
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. M. A. ElSohly
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. I. A. Khan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to I. A. Khan.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Avula, B., Tripathi, L.M., Khan, S.I. et al. LC Method for the Determination of NPC1161, Primaquine and their Metabolites in Various Biological Systems. Chroma 64, 429–434 (2006). https://doi.org/10.1365/s10337-006-0049-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1365/s10337-006-0049-x

Keywords

Search

Navigation